Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 05:40PM GMT
Release Date Price: $17.16 (+1.66%)
Operator

Hello. This webcast presentation is for Bank of America clients only. If you are a member or representative of the media or press, please disconnect now. And now I would like to turn the call over to the moderator. Thank you, and have a good day.

Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research

Thank you, operator. And thank you, everybody, for joining us for our next company fireside chat. I'm pleased to be joined by Bausch Health Company and CEO, Joe Papa. Bausch, those of you very familiar with the company, I'm sure, but Bausch is known for its eye care business, it's GI business and in -- its dermatology business, that are some of the key growth drivers of the business. And so pleased to be joined by Joe.

The company recently reported 1Q update, provided some commentary regarding the impacts of COVID-19 and so from -- we're going to jump into Q&A, but certainly have some follow-ups as it pertains to that and some of the company's key growth drivers. So Joe, first off, thanks for joining us. And I think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot